A surveillance study of branch duct intraductal papillary mucinous neoplasm of the pancreas; a multicenter prospective study.

A surveillance study of branch duct intraductal papillary mucinous neoplasm of the pancreas; a multicenter prospective study. - A surveillance study of branch duct IPMN

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000007349

Enrollment

2000

Registered

2012-03-01

Start date

2012-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Branch duct intraductal mucinous papillary neoplasm of pancreas (BD-IPMN)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed as having BD-IPMN showing dilated branch duct (>10mm), which has a communication with MPD detected by MRCP or ERCP. 2. Patients having fish-eye appearance of duodenal papilla or mucin in pancreatic duct found during ERCP.

Exclusion criteria

Exclusion criteria: 1. absence of communication between cysts and MPD 2. MPD diameter more than 10 mm 3. concomitant with pancreatic ductal adenocarcinoma at diagnosis 4. contraindication for MRCP 5. contraindication for CT 6. contraindication for EUS 7. not given informed consent 8. considered ineligble by attendant doctors

Design outcomes

Primary

Measure	Time frame
the incidences of carcinoma derived from BD-IPMN and ductal carcinoma concomitant with BD-IPMN the progression of BD-IPMN	—

Secondary

Measure	Time frame
prognosis (overall survival time) cyst size, MPD diameter, height of mural nodule age, sex, family history, and operation	—

Countries

Japan

Contacts

Public ContactHiroyuki Maguchi

Teine-Keijinkai Hospital Center for Gastroenterology

maguchi@tb3.so-net.ne.jp011-681-8111

Outcome results